Ameritas Investment Partners’s Standard BioTools LAB Stock Holding History

Ameritas Investment Partners’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,558	Closed	-$27.2K	–	3262
2026 Q1	$27.2K	Hold	29,558	–	–	﹤0.01%	2450
2025 Q4	$37.8K	Hold	29,558	–	–	﹤0.01%	2313
2025 Q3	$38.4K	Hold	29,558	–	–	﹤0.01%	2331
2025 Q2	$35.5K	Hold	29,558	–	–	﹤0.01%	2384
2025 Q1	$31.9K	Hold	29,558	–	–	﹤0.01%	2350
2024 Q4	$51.7K	Hold	29,558	–	–	﹤0.01%	2161
2024 Q3	$57K	Hold	29,558	–	–	﹤0.01%	2112
2024 Q2	$52.3K	Buy	+29,558	New	+$72.2K	﹤0.01%	2121
2022 Q2	–	Sell	-6,011	Closed	-$22K	–	3158
2022 Q1	$22K	Hold	6,011	–	–	﹤0.01%	2518
2021 Q4	$24K	Hold	6,011	–	–	﹤0.01%	2563
2021 Q3	$40K	Hold	6,011	–	–	﹤0.01%	2307
2021 Q2	$37K	Hold	6,011	–	–	﹤0.01%	2386
2021 Q1	$27K	Hold	6,011	–	–	﹤0.01%	2428
2020 Q4	$36K	Hold	6,011	–	–	﹤0.01%	2173
2020 Q3	$45K	Hold	6,011	–	–	﹤0.01%	1907
2020 Q2	$24K	Hold	6,011	–	–	﹤0.01%	2260
2020 Q1	$15K	Hold	6,011	–	–	﹤0.01%	2336
2019 Q4	$21K	Hold	6,011	–	–	﹤0.01%	2391
2019 Q3	$28K	Hold	6,011	–	–	﹤0.01%	2211
2019 Q2	$74K	Buy	6,011 +3,790	+171%	+$48.3K	﹤0.01%	1688
2019 Q1	$30K	Hold	2,221	–	–	﹤0.01%	2156
2018 Q4	$19K	Hold	2,221	–	–	﹤0.01%	2362
2018 Q3	$17K	Hold	2,221	–	–	﹤0.01%	2580
2018 Q2	$13K	Hold	2,221	–	–	﹤0.01%	2734
2018 Q1	$13K	Hold	2,221	–	–	﹤0.01%	2627
2017 Q4	$13K	Hold	2,221	–	–	﹤0.01%	2657
2017 Q3	$10K	Hold	2,221	–	–	﹤0.01%	2770
2017 Q2	$9K	Hold	2,221	–	–	﹤0.01%	2843
2017 Q1	$13K	Buy	+2,221	New	+$14.1K	﹤0.01%	2603

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Ameritas Investment Partners's LAB Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 29,558 shares — an estimated $27.2K sold.

Ameritas Investment Partners first reported a position in LAB in Q1 2017 and held it in 29 quarters. The position peaked at $74K in Q2 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Ameritas Investment Partners reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
Ameritas Investment Partners sold 29,558 Standard BioTools shares in Q2 2026, an estimated $27.2K.
Ameritas Investment Partners first reported a position in Standard BioTools in Q1 2017 and held it in 29 quarters.
Ameritas Investment Partners's Standard BioTools position peaked at $74K in Q2 2019.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.